Moreover, depression also results in a decrease in the level of glucocorticoid receptor (GR), leading to HPA axis disorders, while administration of antidepressant agents can reduce the peripheral level of miR-124, an upstream regulator of GR. This evidence concerns the gene NR3C1 and major depressive disorder.